RESPONDER – diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial

Article English OPEN
Joerg Heil ; Peter Sinn ; Hannah Richter ; André Pfob ; Benedikt Schaefgen ; André Hennigs ; Fabian Riedel ; Bettina Thomas ; Marc Thill ; Markus Hahn ; Jens-Uwe Blohmer ; Sherko Kuemmel ; Maria Margarete Karsten ; Mattea Reinisch ; John Hackmann ; Toralf Reimer ; Geraldine Rauch ; Michael Golatta (2018)
  • Publisher: BMC
  • Journal: BMC Cancer (issn: 1471-2407)
  • Related identifiers: doi: 10.1186/s12885-018-4760-4
  • Subject: Neoadjuvant chemotherapy | 610 Medical sciences Medicine | 610 | RC254-282 | Vacuum-assisted biopsy | Breast cancer | Treatment response evaluation | Neoplasms. Tumors. Oncology. Including cancer and carcinogens

Background: Neoadjuvant chemotherapy (NACT) is a standard approach of the multidisciplinary treatment of breast cancer. Depending on the biological subtype a pathological complete response in the breast (bpCR) can be achieved in up to 60% of the patients. However, only ... View more
Share - Bookmark